Herbert Abramson, a director of Lorus Therapeutics Inc. (LOR.TO) announced that he has acquired 17 million units, consisting of 17 million common shares and warrants exercisable into 8.5 million common shares of Lorus.
Upon completion of acquisition, Abramson owns about 42.83 million shares of Lorus, representing about 14.4% of outstanding common shares of Lorus. In addition, Abramson owns 300,000 stock options and 17.5 million warrants of Lorus.
If Abramson were to exercise all of the options and warrants, he would own about 60.62 million shares, representing about 19.2% of the then issued and outstanding common shares of Lorus.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.